ARCHIVES

Broder, Herberman, Decline To Coauthor Reanalysis of Data

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

In Brief: Thomas Davis Is Named New Director Of NCCP; Senate Subcommittee Give NCI $1.2 Bil. For FY ‘86

September 27, 1985

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

December 7, 1990

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992